{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-28",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 78329
    }
  },
  "results": [
    {
      "safetyreportversion": "1",
      "safetyreportid": "10005341",
      "primarysourcecountry": "FR",
      "occurcountry": "FR",
      "transmissiondateformat": "102",
      "transmissiondate": "20141002",
      "reporttype": "2",
      "serious": "1",
      "seriousnesshospitalization": "1",
      "receivedateformat": "102",
      "receivedate": "20140313",
      "receiptdateformat": "102",
      "receiptdate": "20140313",
      "fulfillexpeditecriteria": "1",
      "companynumb": "FR-ROCHE-1364016",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "ROCHE",
        "duplicatenumb": "FR-ROCHE-1364016"
      },
      "primarysource": {
        "reportercountry": "FR",
        "qualification": "1"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientonsetage": "38",
        "patientonsetageunit": "801",
        "patientsex": "2",
        "reaction": [
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Asthma",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Claustrophobia",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Mood swings",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Nail discolouration",
            "reactionoutcome": "6"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "XOLAIR",
            "drugauthorizationnumb": "103976",
            "drugadministrationroute": "065",
            "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION",
            "actiondrug": "5",
            "openfda": {
              "application_number": [
                "BLA103976"
              ],
              "brand_name": [
                "XOLAIR"
              ],
              "generic_name": [
                "OMALIZUMAB"
              ],
              "manufacturer_name": [
                "Genentech, Inc."
              ],
              "product_ndc": [
                "50242-040",
                "50242-214",
                "50242-215",
                "50242-227"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "SUBCUTANEOUS"
              ],
              "substance_name": [
                "OMALIZUMAB"
              ],
              "rxcui": [
                "1657209",
                "1657212",
                "2058943",
                "2058946",
                "2058949",
                "2058950",
                "2663917",
                "2663918",
                "2663920",
                "2663923",
                "2673760",
                "2673761",
                "2673762",
                "2673763"
              ],
              "spl_id": [
                "e633fdb6-7fbc-4072-93ed-4e30abc6c3a1"
              ],
              "spl_set_id": [
                "7f6a2191-adfb-48b9-9bfa-0d9920479f0d"
              ],
              "package_ndc": [
                "50242-040-62",
                "50242-040-86",
                "50242-214-01",
                "50242-214-86",
                "50242-214-03",
                "50242-214-55",
                "50242-214-99",
                "50242-214-83",
                "50242-215-86",
                "50242-215-01",
                "50242-215-03",
                "50242-215-55",
                "50242-215-99",
                "50242-215-83",
                "50242-227-01",
                "50242-227-55",
                "50242-227-99",
                "50242-227-86"
              ],
              "nui": [
                "N0000175794",
                "N0000175793",
                "N0000175792"
              ],
              "pharm_class_epc": [
                "Anti-IgE [EPC]"
              ],
              "pharm_class_pe": [
                "Decreased IgE Activity [PE]"
              ],
              "pharm_class_moa": [
                "IgE-directed Antibody Interactions [MoA]"
              ],
              "unii": [
                "2P471X1Z11"
              ]
            }
          }
        ]
      }
    }
  ]
}